Доступ предоставлен для: Guest
Портал Begell Электронная Бибилиотека e-Книги Журналы Справочники и Сборники статей Коллекции
Critical Reviews™ in Oncogenesis
SJR: 0.631 SNIP: 0.503 CiteScore™: 2

ISSN Печать: 0893-9675
ISSN Онлайн: 2162-6448

Critical Reviews™ in Oncogenesis

DOI: 10.1615/CritRevOncog.2015013566
pages 199-216

Biology and Treatment of Rhabdoid Tumor

James I. Geller
Division of Oncology, Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio
Jacquelyn J. Roth
Department of Pediatrics, The Children's Hospital of Philadelphia, Philadelphia, Pennsylvania
Jaclyn A. Biegel
Department of Pediatrics, The Children's Hospital of Philadelphia, Philadelphia, Pennsylvania; Department of Pathology and Laboratory Medicine, Children's Hospital Los Angeles; Keck School of Medicine, University of Southern California, Los Angeles, Ca

Краткое описание

Rhabdoid tumor is a rare, highly aggressive malignancy that primarily affects infants and young children. These tumors typically arise in the brain and kidney, although extrarenal, non−central nervous system tumors in almost all soft-tissue sites have been described. SMARCB1 is a member of the SWI/SNF chromatin-remodeling complex and functions as a tumor suppressor in the vast majority of rhabdoid tumors. Patients with germline mutations or deletions affecting SMARCB1 are predisposed to the development of rhabdoid tumors, as well as the genetic disorder schwannomatosis. The current hypothesis is that rhabdoid tumors are driven by epigenetic dysregulation, as opposed to the alteration of a specific biologic pathway. The strategies for novel therapeutic approaches based on what is currently known about rhabdoid tumor biology are presented.

Ключевые слова: rhabdoid, SMARCB1, SWI/SNF

Articles with similar content:

An Updated Review of Oral Cancer Stem Cells and Their Stemness Regulation
Critical Reviews™ in Oncogenesis, Vol.23, 2018, issue 3-4
Reuben H. Kim, Ki-Hyuk Shin
Targeting NOTCH1 in Hematopoietic Malignancy
Critical Reviews™ in Oncogenesis, Vol.16, 2011, issue 1-2
Kimberly Stegmaier, Giovanni Roti
Non-Major Histocompatibility Complex Rheumatoid Arthritis Susceptibility Genes
Critical Reviews™ in Immunology, Vol.31, 2011, issue 2
Saleh M. Ibrahim, Manfred Kunz
Cancer Stem Cells: Root of the Evil
Critical Reviews™ in Oncogenesis, Vol.24, 2019, issue 1
Didem Karakas, Merve Erkisa, Engin Ulukaya
Resistance to Cell Death and Its Modulation in Cancer Stem Cells
Critical Reviews™ in Oncogenesis, Vol.21, 2016, issue 3-4
Ahmad R. Safa